99 related articles for article (PubMed ID: 1373064)
21. Immunologic abnormalities related to antigenaemia during HIV-1 infection.
De Paoli P; Battistin S; Crovatto M; Modolo ML; Carbone A; Tirelli U; Santini G
Clin Exp Immunol; 1988 Dec; 74(3):317-20. PubMed ID: 2976619
[TBL] [Abstract][Full Text] [Related]
22. Isoprinosine (inosine pranobex BAN, INPX) in the treatment of AIDS and other acquired immunodeficiencies of clinical importance.
Glasky AJ; Gordon JF
Cancer Detect Prev Suppl; 1987; 1():597-609. PubMed ID: 2446760
[TBL] [Abstract][Full Text] [Related]
23. Predictive markers for the acquired immunodeficiency syndrome (AIDS) in hemophiliacs: persistence of p24 antigen and low T4 cell count.
Eyster ME; Ballard JO; Gail MH; Drummond JE; Goedert JJ
Ann Intern Med; 1989 Jun; 110(12):963-9. PubMed ID: 2567142
[TBL] [Abstract][Full Text] [Related]
24. Acyclovir vs isoprinosine (immunovir) for suppression of recurrent genital herpes simplex infection.
Kinghorn GR; Woolley PD; Thin RN; De Maubeuge J; Foidart JM; Engst R
Genitourin Med; 1992 Oct; 68(5):312-6. PubMed ID: 1385295
[TBL] [Abstract][Full Text] [Related]
25. A placebo-controlled trial of isoprinosine in patients with multiple sclerosis.
Milligan NM; Miller DH; Compston DA
J Neurol Neurosurg Psychiatry; 1994 Feb; 57(2):164-8. PubMed ID: 7510330
[TBL] [Abstract][Full Text] [Related]
26. Isoprinosine treatment of alopecia areata.
Thiers BH
J Invest Dermatol; 1991 May; 96(5):72S-73S. PubMed ID: 1708797
[No Abstract] [Full Text] [Related]
27. [Isoprinosine treatment of herpes zoster. Résults of a control study in 36 subjects (author's transl)].
Lesourd B; Laude J; Meunier P; Doumerc S; Moulias R
Nouv Presse Med; 1982 Jan; 11(3):191-3. PubMed ID: 6173843
[TBL] [Abstract][Full Text] [Related]
28. Immunosuppressive effects of isoprinosine in man: a comparison to chlorambucil effects in multiple sclerosis.
Pompidou A; Rancurel G; Delsaux MC; Meunier C; Telvi L; Cour V; Buge A
Cancer Detect Prev Suppl; 1987; 1():377-83. PubMed ID: 2446758
[TBL] [Abstract][Full Text] [Related]
29. In-vivo immunomodulation by isoprinosine in patients with the acquired immunodeficiency syndrome and related complexes.
Grieco MH; Reddy MM; Manvar D; Ahuja KK; Moriarty ML
Ann Intern Med; 1984 Aug; 101(2):206-7. PubMed ID: 6204566
[No Abstract] [Full Text] [Related]
30. Seropositivity for HIV and the development of AIDS or AIDS related condition: three year follow up of the San Francisco General Hospital cohort.
Moss AR; Bacchetti P; Osmond D; Krampf W; Chaisson RE; Stites D; Wilber J; Allain JP; Carlson J
Br Med J (Clin Res Ed); 1988 Mar; 296(6624):745-50. PubMed ID: 3126959
[TBL] [Abstract][Full Text] [Related]
31. [Double-blind clinical trial of isoprinosine and placebo in herpetic keratitis].
Haut J; Debrat G; Moulin F; Monin C; Sarnikovski C
Bull Soc Ophtalmol Fr; 1983 May; 83(5):617-20. PubMed ID: 6200245
[No Abstract] [Full Text] [Related]
32. Immunopotentiation of impaired lymphocyte functions in vitro by isoprinosine in prodromal subjects and AIDS patients.
Tsang P; Lew F; O'Brien G; Selikoff IJ; Bekesi JG
Int J Immunopharmacol; 1985; 7(4):511-4. PubMed ID: 2412972
[TBL] [Abstract][Full Text] [Related]
33. Zidovudine monotherapy versus zidovudine plus zalcitabine combination therapy in HIV-positive persons with CD4 cell counts 300-500 cells/mm3: a double-blind controlled trial. The M50003 Study Group Coordinating and Writing Committee.
Moyle GJ; Bouza E; Antunes F; Smith D; Harris R; Warburg M; Walker M
Antivir Ther; 1997 Dec; 2(4):229-36. PubMed ID: 11327442
[TBL] [Abstract][Full Text] [Related]
34. Influence of isoprinosine on lymphocyte function in virus-infected feeder pigs.
Flaming KP; Blecha F; Fedorka-Cray PJ; Anderson GA
Am J Vet Res; 1989 Oct; 50(10):1653-7. PubMed ID: 2478051
[TBL] [Abstract][Full Text] [Related]
35. Normalization of immunoregulatory T-helper T-suppressor sublineages and cell-mediated immunity by isoprinosine in vitro in the early stages of AIDS.
Tsang P; Bekesi JG
Cancer Detect Prev Suppl; 1987; 1():611-8. PubMed ID: 2446761
[TBL] [Abstract][Full Text] [Related]
36. Clinical and immunological assessment in HIV+ subjects receiving inosine-pranobex. A randomised, multicentric study.
De Simone C; Albertini F; Almaviva M; Angarano G; Chiodo F; Costigliola P; Delia S; Ferlini A; Gritti F; Mazzarello G
Med Oncol Tumor Pharmacother; 1989; 6(1):63-7. PubMed ID: 2471025
[TBL] [Abstract][Full Text] [Related]
37. T activation marker evaluation in ARC patients treated with AZT. Comparison with CD4+ lymphocyte count in non-progressors and progressors towards AIDS.
Levacher M; Tallet S; Dazza MC; Dournon E; Rouveix B; Pocidalo JJ
Clin Exp Immunol; 1990 Aug; 81(2):177-82. PubMed ID: 1696859
[TBL] [Abstract][Full Text] [Related]
38. Albendazole chemotherapy for treatment of diarrhoea in patients with AIDS in Zambia: a randomised double blind controlled trial.
Kelly P; Lungu F; Keane E; Baggaley R; Kazembe F; Pobee J; Farthing M
BMJ; 1996 May; 312(7040):1187-91. PubMed ID: 8634560
[TBL] [Abstract][Full Text] [Related]
39. The effect of Isoprinosine treatment on persistent infection of Balb/c mice infected with murine gammaherpesvirus 68.
Janíčková O; Ančicová L; Briestenská K; Mistríková J
Acta Virol; 2017; 61(1):32-38. PubMed ID: 28105852
[TBL] [Abstract][Full Text] [Related]
40. Effect of isoprinosine on in vitro proliferative responses of human lymphocytes stimulated by antigen.
Ballet JJ; Morin A; Schmitt C; Agrapart M
Int J Immunopharmacol; 1982; 4(3):151-7. PubMed ID: 6179890
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
